Applications of Nerve Growth Factor in Pharmaceuticals
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 555
Special Issue Editors
Interests: nerve growth factor; neurotrophins; neuroplasticity; neuronal survival; traumatic brain injury; pediatrics; pediatric emergency medicine; POCUS; clinical trials in pediatrics; point of care ultrasound; lung ultrasound; pediatric epidemiology; global health
Interests: nerve growth factor; neurotrophins; neuroplasticity; neuronal survival; traumatic brain injury; pediatrics; pediatric emergency medicine; clinical trials in pediatrics; children’s health; pediatric epidemiology; global health
Special Issue Information
Dear Colleagues,
Since the pioneering research of Nobel Laureate Rita Levi-Montalcini, nerve growth factor (NGF) has gained increasing attention in the scientific community as a promising candidate for the treatment of several human diseases. NGF has indeed been researched in relation to various neurological disorders, including hypoxic–ischemic encephalopathy, traumatic brain injury, neurobehavioral and neurodevelopmental diseases, congenital malformations, cerebral infections, as well as oncological and ocular diseases. The complex and sophisticated mechanisms by which NGF contributes to neuronal survival and regeneration, some of which are far from understood, represent a vast area of medical research. In recent years, there has been a proliferation of literature on this topic, both preclinical and clinical, with some brilliant results. However, despite the progress made, there are still some controversies regarding the most efficient method of administration and application strategy. A multimodal interdisciplinary approach, based on multiple levels of research and including translational studies, is needed to address the current challenges and to go beyond them through a comprehensive enrichment of new insights and knowledge. For this Special Issue, we hope that researchers from a variety of disciplines will consider contributing.
Dr. Lorenzo Di Sarno
Prof. Dr. Antonio Chiaretti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nerve growth factor
- neurotrophins
- neuroplasticity
- brain injury
- neuronal survival
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
